It is with great pleasure that we announce – and invite you to participate in – the XVIII iwCLL meeting in Edinburgh, Scotland.

For more than 30 years iwCLL has been the largest international meeting focused on bringing together the best minds in the research and care of patients with chronic lymphocytic leukaemia (CLL) to one location for three and a half days every other year.

The upcoming XVIII iwCLL is no exception. The 2019 meeting will once again bring together a diverse selection of expert haematologists, clinicians, and researchers from around the world to discuss all aspects of CLL – from recent developments in the understanding of CLL biology, to innovations in diagnosis and prognosis, to strategies for treatment selection amidst a rapidly changing landscape, to recent clinical and real-world data with new and emerging agents.

As always, the iwCLL program will provide presenters a forum to share critical updates while providing all attendees an opportunity to actively engage presenters, make important connections, gain insight into the latest treatment strategies, and leave inspired to continue advancing the care for patients with CLL.

iwCLL 2019 special sessions will include:
– The CLL (Epi)genome
– BCR
– Microenvironment and Models of CLL
– Innovations in the Assessment of CLL
– Initial Therapy
– Clonal Evolution and Resistance Mechanisims
– Real-World Data and Registeries

On behalf of the organizing committee, we hope you will join us for iwCLL 2019. More information about how to participate and help advance the field of CLL – as an attendee, presenter, sponsor or exhibitor-will be posted on the website in the coming months.